Skip to main content

OWN
TECHNOLOGY

Our own technologies allow us to develop advanced and personalized biomedical solutions, adapted to the needs of the market and aligned with global health challenges.

14

Technological patents

20

medical devices

+172

R&D projects

+100

top notch researchers

Let's talk about i+Med product

WEB_06_26_I+MED 18.webp

CONTROLLED RELEASE SYSTEMS

We are experts in intersecting three-dimensional polymer networks

We are experts in intersecting three-dimensional polymer networks

that act as Controlled Release Systems In response to stimuli such as pH, time and temperature.

HYDROGELS

Biocompatibles

sterilized

Patent

GMPS

scalable

Highly moisturable polymeric matrices that combine versatility, biocompatibility and industrial scalability.

Highly moisturable polymeric matrices that combine versatility, biocompatibility and industrial scalability.

Their ability to form stable and adaptable structures makes them an effective and reliable solution for a wide variety of technological applications.


  1. hyaluronic acid
  2. chondroitin sulfate
  3. alginate
  4. chitosan
  5. CMC
  6. HPCM
  7. xanthan gum
  8. X-DNA
  9. collagen
  10. Non-animal collagen
  11. Synthetic

Nanohydrogels

hydrogels in nanometric scale.

hydrogels in nanometric scale.

Greater penetration capacity and response to stimuli. This makes them an especially effective solution in applications where high precision and efficiency are required.

Nanocarriers

nanometric capsules.

nanometric capsules.

Using an intelligent matrix of nanohydrogel, they vectorize and release the active compounds in a controlled manner, improving their efficiency and absorption.

14 patents support our technology

WEB_06_26_I+MED 18.webp

Biocompatible microgels and their applications

PCT/EP2021/083550

Composition of seawater and submicroparticles with cannabinoids

PCT/EP2021/083550

Multilayer coating to cover implants

PCT/ES2021/070830

In i+MED, innovation is not just a value.

It is the basis on which we build solutions that seek to transform health. We combine scientific research and technological development to generate a constant pipeline of projects with real impact.

research programs

I+MED actively participates in international research consortia with teams of universities and specialized companies to innovate in the field of intelligent nanotechnologies around biomaterials for controlled release of active substances.